Breast Cancer - Therapy
Patient Preferences for Treatment of Metastatic Breast Cancer: A Study of Women with Early-Stage Breast Cancer
Published in Women's Health Weekly, May 15th, 1995
According to the authors' abstract of an article published in Journal of Clinical Oncology, "Purpose: The purpose of this study was to elicit preferences for the treatment of metastatic breast cancer in women with early-stage breast cancer who were given hypothetical treatment scenarios. We predicted that quality of life, demographic, and treatment variables would have an impact on patient preferences. Patients and Methods: One hundred fifteen patients with stage I-IIIA breast cancer were interviewed. All patients had either mastectomy or lumpectomy plus radiotherapy as primary treatment. Sixty-seven (58%) had prior adjuvant chemotherapy. Patients were given four...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Obstetrics - Populations at Risk
Caesarean Section Associated with Increased Nosocomial Infections - Breast Cancer - Diagnostics
Screenings Separated by Economic and Insurance Status - Breast Cancer - Therapy
Research Aided by New Understanding of Tamoxifen Activity - Breast Cancer - Therapy
Vinorelbine/Paclitaxel Combination Appears Promising - HTLV-II
Study Links Sexual and Mother-to-Child Transmission - Kaposi's Sarcoma
Placental Hormone May Help Treat KS - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
